A Multi-centre Randomised Double Blind Placebo Controlled Study Comparing Two Regimens of Combination Therapy in Early DMARD Naive Rheumatoid Arthritis.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 05 Aug 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Infliximab (Primary) ; Methotrexate; Methylprednisolone; Methylprednisolone
Indications Rheumatoid arthritis
Focus Biomarker; Therapeutic Use
Acronyms IDEA

16 Sep 2016 Results of a cardiovascular substudy (n=79) published in the Rheumatology
29 Oct 2013 Results of the cardiovascular analysis (n=79) presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
09 Jun 2012 Results assessing changes in levels of cardiovascular biomarkers presented at the 13th Annual Congress of the European League Against Rheumatism.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com